Artiva Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 9.85 M | $63.46 M | 0.00% | 40.31% |
| 5AM VENTURE MANAGEMENT, LLC | 05/15/2026 | 2.35 M | $15.16 M | 0.00% | 9.63% |
| VR ADVISER, LLC | 05/15/2026 | 1.61 M | $10.37 M | 0.00% | 6.58% |
| VENBIO PARTNERS LLC | 05/15/2026 | 531.34 K | $3.42 M | -18.07% | 2.17% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 520.33 K | $3.35 M | 0.00% | 2.13% |
| REVELATION CAPITAL MANAGEMENT, LLC | 05/15/2026 | 299.31 K | $1.93 M | 0.00% | 1.22% |
| BLACKROCK, INC. | 05/13/2026 | 213.39 K | $1.37 M | 0.40% | 0.87% |
| 05/15/2026 | 207.69 K | $1.34 M | 100.00% | 0.85% | |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 194.11 K | $1.25 M | 0.00% | 0.79% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 146.37 K | $949.82 K | 100.00% | 0.60% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 123.27 K | $793.86 K | -43.22% | 0.50% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 115.04 K | $740.86 K | -20.59% | 0.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 101.70 K | $655.45 K | 0.57% | 0.42% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 100.00 K | $644.00 K | 0.00% | 0.41% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 80.04 K | $515.45 K | -31.12% | 0.33% |
| JANE STREET GROUP, LLC | 05/12/2026 | 39.50 K | $254.35 K | -2.89% | 0.16% |
| STATE STREET CORP | 05/15/2026 | 35.82 K | $230.71 K | 0.00% | 0.15% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 35.00 K | $225.40 K | 0.00% | 0.14% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 32.81 K | $211.30 K | 100.00% | 0.13% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 30.70 K | $197.72 K | 100.00% | 0.13% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 25.00 K | $161.00 K | 100.00% | 0.10% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 23.23 K | $149.60 K | 100.00% | 0.10% |
| SANCTUARY ADVISORS, LLC | 05/05/2026 | 21.58 K | $138.98 K | 100.00% | 0.09% |
| BAILARD, INC. | 05/11/2026 | 20.70 K | $133.31 K | 100.00% | 0.08% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 20.37 K | $131.18 K | 100.00% | 0.08% |
| XTX TOPCO LTD | 05/15/2026 | 20.27 K | $130.54 K | 100.00% | 0.08% |
| MORGAN STANLEY | 05/15/2026 | 16.38 K | $105.47 K | -39.51% | 0.07% |
| CITADEL ADVISORS LLC | 05/15/2026 | 15.87 K | $102.20 K | 100.00% | 0.06% |
| NORTHERN TRUST CORP | 05/14/2026 | 12.21 K | $78.62 K | 100.00% | 0.05% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 11.47 K | $73.84 K | -4.93% | 0.05% |
| OMERS ADMINISTRATION CORP | 05/15/2026 | 11.40 K | $73.42 K | -45.97% | 0.05% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/08/2026 | 5.49 K | $35.36 K | 0.00% | 0.02% |
| FMR LLC | 05/15/2026 | 3.53 K | $22.73 K | -0.82% | 0.01% |
| UBS GROUP AG | 05/05/2026 | 1.53 K | $9.83 K | -95.86% | 0.01% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 1.50 K | $9.66 K | 0.00% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 542 | $3.49 K | 0.00% | 0.00% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 05/11/2026 | 400 | $4.24 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 223 | $1.22 K | 19.25% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 188 | $1.00 K | -44.54% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 18 | $116 | -43.75% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Artiva Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 46 institutional investors and hedge funds held shares of Artiva Biotherapeutics Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 9.85 M
5AM Venture Management, LLC: 2.35 M
VR Adviser, LLC: 1.61 M
venBio Partners LLC: 531,337
FRANKLIN RESOURCES INC: 520,327
Revelation Capital Management, LLC: 299,311
68.87% of Artiva Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 16.89 M shares in the last 24 months. This purchase volume represents approximately $96.45 M in transactions.